Search for a trial

Phase II, Multi-Center, Randomized, Blinded Study Evaluating the Efficacy, Safety and Tolerability of a Single Intratympanic Dose of AC102 Compared to Oral Steroids for the Treatment of Idiopathic Sudden Sensorineural Hearing Loss.

This study has been transitioned to CTIS with ID 2024-513658-31-00 check the CTIS register for the current data. The primary objective of this study is to assess the efficacy of a single intratympanic injection of AC102 compared to oral steroids in…